X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
humans (5) 5
middle aged (5) 5
adult (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
cancer (4) 4
care and treatment (4) 4
female (4) 4
index medicus (4) 4
oncology (4) 4
treatment outcome (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer therapies (3) 3
disease-free survival (3) 3
drug therapy (3) 3
hematology, oncology and palliative medicine (3) 3
male (3) 3
metastasis (3) 3
product development (3) 3
studies (3) 3
survival (3) 3
1st-line treatment (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
colorectal cancer (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - mortality (2) 2
colorectal neoplasms - pathology (2) 2
combination (2) 2
disease (2) 2
infusions, intravenous (2) 2
lymphoma, mantle-cell - drug therapy (2) 2
lymphomas (2) 2
maintenance (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
patient outcomes (2) 2
prognosis (2) 2
research (2) 2
rituximab (2) 2
survival rate (2) 2
abridged index medicus (1) 1
acquired-resistance (1) 1
adolescent (1) 1
advanced follicular lymphoma (1) 1
amplification (1) 1
anthracyclines (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
austria (1) 1
b-cell (1) 1
bendamustine (1) 1
bendamustine hydrochloride (1) 1
bendamustine hydrochloride - administration & dosage (1) 1
bendamustine hydrochloride - adverse effects (1) 1
bevacizumab (1) 1
bevacizumab - administration & dosage (1) 1
blood-pressure (1) 1
bone marrow (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - pathology (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - therapeutic use (1) 1
cancer patients (1) 1
cancer research (1) 1
cardiovascular disease (1) 1
cetuximab (1) 1
cetuximab - administration & dosage (1) 1
clinical neurology (1) 1
clinical trials (1) 1
clinical-trials (1) 1
comparative analysis (1) 1
complications and side effects (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - adverse effects (1) 1
depth (1) 1
disease progression (1) 1
docetaxel (1) 1
dosage and administration (1) 1
dose-response relationship, drug (1) 1
doxorubicin - administration & dosage (1) 1
doxorubicin - adverse effects (1) 1
drug administration schedule (1) 1
drug therapy, combination (1) 1
efficacy (1) 1
fludarabine (1) 1
fluorouracil (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - therapeutic use (1) 1
follicular lymphoma (1) 1
genes (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1065 - 1075
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. 1426 - 1434
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 57 - 66
Journal Article
Journal Article
by Chauhan, Ganesh and Adams, Hieab H.H and Satizabal, Claudia L and Bis, Joshua C and Teumer, Alexander and Sargurupremraj, Muralidharan and Hofer, Edith and Trompet, Stella and Hilal, Saima and Smith, Albert Vernon and Jian, Xueqiu and Malik, Rainer and Traylor, Matthew and Pulit, Sara L and Amouyel, Philippe and Mazoyer, Bernard and Zhu, Yi-Cheng and Kaffashian, Sara and Schilling, Sabrina and Beecham, Gary W and Montine, Thomas J and Schellenberg, Gerard D and Kjartansson, Olafur and Guðnason, Vilmundur and Knopman, David S and Griswold, Michael E and Windham, B Gwen and Gottesman, Rebecca F and Mosley, Thomas H and Schmidt, Reinhold and Saba, Yasaman and Schmidt, Helena and Takeuchi, Fumihiko and Yamaguchi, Shuhei and Nabika, Toru and Kato, Norihiro and Rajan, Kumar B and Aggarwal, Neelum T and De Jager, Philip L and Evans, Denis A and Psaty, Bruce M and Rotter, Jerome I and Rice, Kenneth and Lopez, Oscar L and Liao, Jiemin and Chen, Christopher and Cheng, Ching-Yu and Wong, Tien Y and Ikram, Mohammad K and van der Lee, Sven J and Amin, Najaf and Chouraki, Vincent and DeStefano, Anita L and Aparicio, Hugo J and Romero, Jose R and Maillard, Pauline and DeCarli, Charles and Wardlaw, Joanna M and Hernández, Maria del C Valdés and Luciano, Michelle and Liewald, David and Deary, Ian J and Starr, John M and Bastin, Mark E and Muñoz Maniega, Susana and Slagboom, P Eline and Beekman, Marian and Deelen, Joris and Uh, Hae-Won and Lemmens, Robin and Brodaty, Henry and Wright, Margaret J and Ames, David and Boncoraglio, Giorgio B and Hopewell, Jemma C and Beecham, Ashley H and Blanton, Susan H and Wright, Clinton B and Sacco, Ralph L and Wen, Wei and Thalamuthu, Anbupalam and Armstrong, Nicola J and Chong, Elizabeth and Schofield, Peter R and Kwok, John B and van der Grond, Jeroen and Stott, David J and Ford, Ian and Jukema, J Wouter and Vernooij, Meike W and Hofman, Albert and Uitterlinden, André G and van der Lugt, Aad and Wittfeld, Katharina and Grabe, Hans J and Hosten, Norbert and von Sarnowski, Bettina and Völker, Uwe and Levi, Christopher and Jimenez-Conde, Jordi and ... and Stroke Genetics Network SiGN and CHARGE Consortium and ISGC and METASTROKE and ADGC and Stroke Genetics Network (SiGN), the International Stroke Genetics Consortium (ISGC), METASTROKE, Alzheimer's Disease Genetics Consortium (ADGC), and the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and Institutionen för biomedicin and Sahlgrenska akademin and Institute of Biomedicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Neurology, ISSN 0028-3878, 01/2019, Volume 92, Issue 5, pp. e486 - e503
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.